Tag: Big Pharma

The budget office said it now expects the provision of Trump’s One Big Beautiful Bill Act to cost $8.8 billion over the next 10 years.

More than 1,000 women say Pfizer ignored evidence linking Depo-Provera to brain tumors—and used the FDA’s decision to protect itself.

Senate HELP Minority report says 688 drug prices rose after Trump took office, with some cancer therapies now over $200,000 a year and a rare-disease drug jumping 1,555 percent; White House tariffs and the One Big Beautiful Bill Act could push costs higher still.

Senate parliamentarian reverses an earlier ruling, letting a provision that shields multi-use orphan drugs from Medicare price talks ride on Republicans’ budget package as patient advocates warn of higher costs for taxpayers and seniors.

Order pushes for four-year delay in Medicare price talks for most prescription drugs, echoing pharma lobby demands and risking higher costs for patients.

The suit also includes their affiliated group purchasing organizations (GPOs), accusing them of blocking patients from accessing cheaper alternatives and distorting drug markets for profit.

The Federal Trade Commission intensifies its fight against pharmaceutical patent abuses, aiming to slash drug prices and increase access to generic medications.

"We are moving ahead to help people in spite of pharma's efforts to block negotiation in the courts."

Florida's groundbreaking move: importing affordable medication from Canada. Big Pharma's pushback and the FDA's historic approval — a turning point in U.S. healthcare?

An analysis of the $6 billion in grants distributed by PhRMA and its member companies.